– Lam Research Corp. (NASDAQ: LRCX) reported first-quarter 2020 adjusted earnings of $3.18 per share, vs. $3.01 per share expected.
– September-quarter unadjusted earnings were $3.09 per share, vs. $3.23 per share last year
– Revenues declined 7% year-over-year to $2.17 billion, vs. $2.16 billion expected
– Forecasts second-quarter revenues of $2.5 billion
– Looking for Q2 adjusted earnings of $3.80 per share; reported earnings of $3.71 per share
– Lam Research shares gained 66% since the beginning of 2019; gained further during Wednesday’s after-hours sesson
Most Popular
Agentforce in focus as Salesforce (CRM) gets ready for Q3 2025 earnings
After delivering mixed results in the first half, Salesforce, Inc. (NYSE: CRM) looks poised to report strong numbers when it publishes third-quarter results next week. The Customer relationship management platform
What to look for when Dollar Tree (DLTR) reports Q3 2024 earnings
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) rose over 5% on Monday. The stock has dropped 27% over the past three months. The discount store chain is scheduled to report
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
